Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial

This follow-up study of the CORIMUNO-TOCI-1 randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Intern Med
Autors principals: Mariette, Xavier, Hermine, Olivier, Tharaux, Pierre-Louis, Resche-Rigon, Matthieu, Steg, Philippe Gabriel, Porcher, Raphaël, Ravaud, Philippe
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2021
Matèries:
Research Letter
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145157/
https://ncbi.nlm.nih.gov/pubmed/34028504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2021.2209
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars